secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2022-06-08T23:59:59+00:00
Accession:  0001100682-22-000023
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River lowers Q2 2022 revenue and EPS outlook, cites FX and CDMO headwinds
--------------------------------------------------------------------------------

- Q2 reported revenue growth guidance cut from low-double-digit to high-single-digit YoY; non-GAAP EPS growth cut from mid- to high-single-digit to low- to mid-single-digit.
- Guidance reduction driven by unfavorable FX impact and manufacturing (CDMO) revenue growth below Q1 2022 level.
- DSA and RMS organic growth rates expected to accelerate from Q1; DSA trends remain in line with full-year expectations.
- Full-year 2022 organic revenue growth and non-GAAP EPS guidance maintained within prior ranges provided in May.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/0001100682-22-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000023/crl-20220608.htm
  HTML page:      https://secwatch.observer/filing/0001100682-22-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer